John Beresh, MD
Pain Medicine · Hamilton, OHNPI 1700845344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 429 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by Vertos Medical, Inc. at 26.4% of the total.
Across 429 payments — averaging $26.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$3K
- Abbott$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Medtronic$993
- Nevro Corp.$546
- Collegium Pharmaceutical, Inc.$499
- plus $4K from 31 others
What the payments were for
- Travel & lodging$8187%
- Food & beverage$10,71393%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 36 | $3,047 |
| Abbott | 54 | $1,281 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 85 | $1,208 |
| Medtronic | 24 | $993 |
| Nevro Corp. | 19 | $546 |
| Collegium Pharmaceutical, Inc. | 32 | $499 |
| AbbVie | 30 | $427 |
| Pfizer | 39 | $396 |
| Boston Scientific | 13 | $375 |
| Biotronik NRO, Inc. | 7 | $369 |
| Saluda Medical Americas, Inc. | 3 | $345 |
| GRT US Holding, Inc. | 12 | $203 |
| Stryker | 2 | $194 |
| Amgen | 6 | $176 |
| Biodelivery Sciences International, Inc. | 12 | $153 |
| Teva Pharmaceuticals USA, Inc. | 6 | $148 |
| Avanos Medical | 1 | $148 |
| Almatica Pharma LLC | 7 | $146 |
| Nalu Medical, Inc. | 2 | $137 |
| Stimwave Technologies Incorporated | 1 | $131 |
| IBSA Pharma Inc. | 7 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $66 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Redhill Biopharma Inc. | 4 | $54 |
| Curonix LLC | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Averitas Pharma Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Si-bone, Inc. | 2 | $28 |
| Novartis | 2 | $26 |
| Vertex | 1 | $18 |
| Forte Bio-pharma LLC | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| MDD US Operations, LLC | 1 | $15 |
| Valinor Pharma, LLC | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Shionogi Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$2,727
- PROCLAIM$410
- INTELLIS ADAPTIVESTIM$404
- Evoke$245
- INTELLIS$149
- Proclaim IPG$149
- COOLIEF* COOLED RADIOFREQUENCY$148
- CLINICAL TRIAL PRODUCT$144
- INCEPTIV$139
- StimQ Receiver Stimulator Kit Channel A US w Receiver$131
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$131
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$131
- Freedom 4A Receiver Kit Channel A US w Receiver$131
- Freedom 8A Receiver Kit Channel A US w Receiver$131
- Omnia$128
- AJOVY$118
- AIMOVIG$115
- Prospera$110
- Senza Spinal Cord Stimulation System$104
How this compares
$11,542 in reported general payments places this provider in the 85th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 11 | $27,752 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 582 | $17,074 |
| MovantikNaloxegol Oxalate | 17 | $8,587 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 371 | $8,393 |
| Oxycodone Hcl | 283 | $5,789 |
| Morphine Sulfate ErMorphine Sulfate | 158 | $3,045 |
| Methadone Hcl | 151 | $2,291 |
| Pregabalin | 38 | $1,897 |
| Lidocaine | 19 | $1,417 |
| Gabapentin | 104 | $1,101 |
| Diclofenac Sodium | 22 | $615 |
| Hydromorphone Hcl | 37 | $599 |
| Methocarbamol | 35 | $467 |
| Tramadol Hcl | 48 | $368 |
| Morphine Sulfate | 26 | $349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,208 | $27,75211 claims |
| Redhill Biopharma Inc.Movantik | $54 | $8,58717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Hamilton
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.